Renaissance Capital logo

CABA News

US IPO Week Ahead: Another quiet week for the IPO market with 1 biotech

WIMI

Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for...read more

US IPO Weekly Recap: IPO market serves up tricks and treats in diverse 8-IPO week

ONEW

In the busiest week since July, eight companies entered the public market while recreational boat retailer OneWater Marine (ONEW) postponed its $60 million deal. Two insurance plays and a biotech traded up more than 15%, while ...read more

Autoimmune biotech Cabaletta Bio prices IPO well below the range at $11

Cabaletta Bio logo

Cabaletta Bio, a Phase 1-ready biotech developing engineered T cells for autoimmune diseases, raised $75 million by offering 6.8 million shares at $11, below the range of $14 to $16. The company sold 1.0 million more shares than expected. At the offer price,...read more

US IPO Week Ahead: IPO market ramps up with 8 deals despite investor caution

PGNY

Up to eight companies are set to raise $831 million in the week ahead. Florida insurance brokerage BRP Group (BRP) is the largest by deal size, while employee benefits provider Progyny (PGNY) and Chinese education company Youdao (DAO) target...read more